Compounded Bioidentical Hormone Therapy Market Share

North America industry is expected to account for largest revenue share by 2037, on the back of higher healthcare expenditure, increasing thyroid prevalence amongst women, and more awareness amongst the people. According to a report by American Thyroid Association, one in eight women will develop a thyroid disorder during her lifetime. Furthermore, scientists are proactive to find out remedies for menopause-related issues, which is the reason the global compounded bioidentical hormone therapy is expected to propel over the forecast period.

The Europe region is also projected to witness considerable growth in the compounded bioidentical hormone therapy market over the forecast period owing to the higher disposable income of people, and robust healthcare infrastructure.